Quaker Chemical CORP

Quaker Houghton announced a 10% year-over-year increase in net sales to $532.6 million and a 28% rise in non-GAAP earnings per diluted share to $2.19 for the second quarter of 2026.

Quaker Chemical Corporation reports the resignation of its Vice President, Corporate Controller, and Principal Accounting Officer, Steven Dassing, effective July 22, 2026, with CFO Coler assuming the Principal Accounting Officer role.

Quaker Chemical Corporation announced the retirement of Chairman Michael F. Barry and the appointment of Mark A. Douglas as the new Chairman, effective May 13, 2026.

Quaker Houghton reported an 8% year-over-year increase in Q1 2026 net sales to $480.5 million, driven by organic volume growth and new business wins.

Quaker Chemical Corporation has amended its credit agreement, extending debt maturities to 2031 and increasing available revolving credit.

Quaker Chemical Corporation announced the departure of Jeffrey Fleck, Senior Vice President, Chief Global Operations Officer, effective March 9, 2026.

Quaker Chemical Corporation announced a 10% increase in net sales for the second quarter of 2026, reaching $532.6 million, driven by higher volumes and favorable currency translation.

Quaker Houghton reported an 8% increase in Q1 2026 net sales to $480.5 million, driven by acquisitions and organic volume growth.

Quaker Houghton reported a 7% increase in third-quarter net sales driven by acquisitions and organic volume growth, but a significant goodwill impairment charge in EMEA led to a net loss for the nine-month period.

Quaker Houghton reported a significant net loss in the second quarter of 2025, primarily due to an $88.8 million goodwill impairment charge in its EMEA segment, despite a slight increase in net sales driven by recent acquisitions.

Quaker Houghton reports a 6% decrease in net sales for Q1 2025, primarily due to lower sales volumes, unfavorable currency translation, and a decline in selling price and product mix.

Quaker Houghton's Q3 2024 results show a 6% decrease in net sales compared to the same period last year, primarily due to lower selling prices and reduced volumes.

Quaker Houghton reported a net loss of $2.5 million for 2025, primarily due to an $88.8 million goodwill impairment charge in its EMEA segment, despite a 3% increase in net sales driven by acquisitions.

Quaker Houghton's 2024 results reflect a 6% decrease in net sales, influenced by pricing, volume, and currency fluctuations, alongside strategic acquisitions aimed at bolstering its market position.

Quaker Houghton files an amendment to its 2023 annual report to correct a clerical error in its contractual obligations table, while highlighting strong earnings growth driven by value-based pricing and margin improvements.

Quaker Houghton welcomes a new VP, Chief Accounting Officer, and releases its annual 10-K filing, detailing financial performance, strategic initiatives, and risk factors.

Jeewat Bijlani, EVP, Glob. Spec. & CGO of Quaker Chemical Corp, reported a transaction in 7 shares of common stock on August 7, 2026.

William H Osborne, a Director of Quaker Chemical Corp, sold 600 shares of common stock on August 4, 2026 for $168.31 per share.

Thomas Coler, EVP and CFO of Quaker Chemical Corp, reported transactions involving restricted stock units and dividend equivalent rights.

Lucrece Foufopoulos-De Ridder, a Director at Quaker Chemical Corp, reported transactions involving common stock, including share acquisitions and surrenders for tax obligations.

Director Lucrece Foufopoulos-De Ridder reported the vesting of restricted stock units and a new equity grant for Quaker Houghton.

Mark Douglas, a Director at Quaker Chemical Corp (KWR), reported transactions involving the acquisition and disposition of common stock and restricted stock units.

Quaker Houghton reported a $2.5 million net loss for 2025, impacted by significant impairment and restructuring charges, despite achieving new business wins and positive operating cash flow.

Quaker Houghton announces its 2025 Annual Meeting of Shareholders to be held virtually on May 7, 2025, detailing proposals for director elections, executive compensation, and auditor ratification.

Quaker Houghton's proxy statement details proposals for director elections, executive compensation, and the approval of a new long-term incentive plan, alongside corporate governance updates.

QH Hungary Holdings Limited has amended and restated several prepaid variable share forward transactions with Citibank and RBC to extend settlement dates.

QH Hungary Holdings Limited updated its Schedule 13D filing, detailing amendments to existing prepaid variable share forward transactions and new agreements with Citibank and Royal Bank of Canada to extend settlement dates and raise financing.

Gulf Hungary Holding Korlatolt Felelossegu Tarsasag and its subsidiary QH Hungary Holdings Limited have filed an amendment to their Schedule 13D, detailing the restatement of a significant prepaid variable share forward transaction with Citibank, N.A. to facilitate financing.

Gulf Hungary Holding and QH Hungary Holdings Limited have updated their beneficial ownership in Quaker Chemical Corporation to 20.9% and 20.8% respectively, following the partial settlement of variable prepaid forward contracts.

Gulf Hungary Holding and its subsidiary QH Hungary Holdings have updated their beneficial ownership in Quaker Chemical Corporation after partially settling variable prepaid forward contracts, maintaining a significant stake.

Gulf Hungary Holding and its subsidiary QH Hungary Holdings Limited have updated their beneficial ownership in Quaker Chemical Corporation, reflecting a partial settlement of variable prepaid forward sale contracts.

Vanguard Portfolio Management has reported beneficial ownership of 934,704 shares, representing 5.39% of Quaker Chemical Corp's common stock, as of March 31, 2026.

The Vanguard Group has filed an amended Schedule 13G, reporting a 0% beneficial ownership in Quaker Chemical Corp common stock following an internal realignment.

BlackRock, Inc. has filed an amended Schedule 13G, revealing its beneficial ownership of 11.5% of Quaker Chemical Corp's common stock as of March 31, 2025.